XML 38 R23.htm IDEA: XBRL DOCUMENT

Equity - contributed equity

12 Months Ended

Jun. 30, 2022

Note 18. Equity - contributed equity


	Consolidated
	2022		2021		2022		2021
	Shares		Shares		$		$

Ordinary shares - fully paid		138,755,376		132,012,209		84,480,249		80,290,062

Movements in ordinary share

capital


Details	Date	Shares		Issue price		$

Balance	1 July 2020		94,598,369				48,781,214
Issued on conversion of options	28 August 2020		25,000	$	0.4930		12,313
Institutional placement under ANREO	12 October 2020		20,525,820	$	0.8000		16,420,656
Retail placement under ANREO	26 October 2020		11,017,075	$	0.8000		8,813,660
Issued on conversion of options	2 March 2021		391,500	$	0.6350		248,661
Issued on conversion of options	15 March 2021		25,000	$	0.4930		12,313
Share placement	28 April 2021		3,037,580	$	1.4070		4,274,633
Issued on achievement of milestone	21 May 2021		2,391,865	$	1.4210		3,400,000
Less: share issue transaction costs			—	$	0.0000		(1,673,388	)


Balance	30 June 2021		132,012,209				80,290,062

Issued on conversion of options	15 December 2021		25,000	$	0.6680		16,700
Conversion of Triaxial Convertible Note	5 May 2022		1,855,357	$	0.2500		464,000
ATM issue of shares No. 1	24 May 2022		10,000	$	0.8260		8,256
ATM issue of shares No. 2	2 June 2022		10,000	$	0.8020		8,025
ATM issue of shares No. 3	6 June 2022		88,710	$	0.8370		74,258
ATM issue of shares No. 4	9 June 2022		603,500	$	0.8400		507,035
ATM issue of shares No. 5	14 June 2022		75,940	$	0.8240		62,583
ATM issue of shares No. 6	15 June 2022		2,000	$	0.8300		1,661
ATM issue of shares No. 7	20 June 2022		4,072,660	$	0.8690		3,540,403
Less: share issue transaction costs			—	$	0.0000		(492,734	)


Balance	30 June 2022		138,755,376				84,480,249

Ordinary shares

Ordinary shares entitle the holder to participate in dividends and the proceeds on the winding up of the company in proportion to the number of and amounts paid on the shares held. The fully paid ordinary shares have no par value and the company does not have a limited amount of authorised capital.

On a show of hands every member present at a meeting in person or by proxy shall have one vote and upon a poll each share shall have one vote.

buy-back

There is no current

on-market

buy-back.

Capital risk management

The consolidated entity’s objectives when managing capital are to safeguard its ability to continue as a going concern, so that it can provide returns for shareholders and benefits for other stakeholders and to maintain an optimum capital structure to reduce the cost of capital.

Capital is regarded as total equity, as recognised in the statement of financial position, plus net debt. Net debt is calculated as total borrowings less cash and cash equivalents.

The capital structure of the consolidated entity consists of cash and cash equivalents and equity attributable to equity holders. The overall strategy of the consolidated entity is to continue its drug development programs, which depends on raising sufficient funds, through a variety of sources including issuing of additional share capital, as may be required from time to time.

The capital risk management policy remains unchanged from the prior year.